This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Zetascience Gmbh. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Dorit Meinhold: Innovator in Bioactive Hydrogels
Introduction
Dorit Meinhold is a prominent inventor based in Dresden, Germany. She has made significant contributions to the field of bioactive materials, particularly through her innovative work on hydrogels. Her research focuses on creating hybrid materials that can have various applications in biomedical fields.
Latest Patents
Dorit Meinhold holds a patent for a bioactive hydrogel. This invention relates to a hybrid material composed of heparin and star-branched polyethylene glycol with functionalized end groups. The heparin is covalently bound to the polyethylene glycol through amide bonds, achieved by reacting activated carboxyl groups with terminal amino groups using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimides/N-hydroxysulfosuccinimide (EDC/s-NHS). This innovative approach enhances the functionality of the hydrogel for potential biomedical applications.
Career Highlights
Dorit Meinhold has established herself as a key figure in her field. Her work at Zetascience GmbH has allowed her to explore and develop new materials that can significantly impact medical technology. With her expertise, she has contributed to advancing the understanding and application of bioactive hydrogels.
Collaborations
Throughout her career, Dorit has collaborated with notable colleagues, including Carsten Werner and Uwe Freudenberg. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Dorit Meinhold's contributions to the field of bioactive hydrogels exemplify her dedication to innovation and research. Her patent and work at Zetascience GmbH highlight her role as a leading inventor in this important area of study.